In conclusion, Tet2ΔMye-induced myeloid hematopoiesis exacerbates liver fibrosis in both young and aging mice through a consistent Ccl2/Ccl8–pMDMs–IL-6–HSCs pathway highlighting a unified therapeutic target for age-associated fibrosis. The gene discussed is IL6; the disease is Hepatic fibrosis.